ROCKVILLE, MD., Feb. 23, 2016 -- The Regulatory Affairs Professionals Society (RAPS) today launched its global survey of regulatory professionals who work with healthcare and related products. RAPS' Scope of Practice & Compensation Survey of the Regulatory Profession, conducted every two years, is the largest and most comprehensive survey of professionals in this important field, vital to ensuring healthcare products are safe and effective.
Respondents work in the pharmaceutical, biotechnology and medical device industries, government agencies, academia, consultancies and other settings where regulatory expertise is needed. Those completing the 10–15-minute survey answer questions about their jobs, backgrounds and compensation, and all answers are kept confidential and anonymous. The results will be released this summer.
RAPS also is offering participants the option to receive free advance access to the results, as well as a chance to win one of four $250 (US) Amazon gift cards to be given away to respondents over the course of the next two months. In addition, those who have the Regulatory Affairs Certification (RAC) credential also receive one point toward their recertification requirement.
Regulatory professionals located anywhere in the world are invited to complete the survey online at http://ow.ly/YF1mc.
RAPS has conducted similar research on the regulatory profession for more than 25 years. The 2014 survey drew responses from more than 3,300 regulatory professionals in 62 countries. According to the resulting 2014 Scope of Practice & Compensation Report, regulatory professionals' salaries rose an average of 5.4% from 2012 to 2013. RAPS' analysis of the responses showed that job level, regulatory experience, highest-earned degree, total professional experience and having the RAC credential have significant influence on compensation.
The survey results will be very useful to regulatory professionals and talent managers wishing to benchmark salaries and compensation packages. It also provides insight to help RAPS track trends and drive greater awareness and understanding of the importance of the profession.
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. http://www.RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245
[email protected]


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



